Skip to content

The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

The U.S. Generic & Biosimilar Medicines Savings Report (Sep. 2022)

The Global Use of Medicines 2023

National trends in prescription drug expenditures and projections for 2022

Biosimilars: Considerations for Payers

Projected US Savings From Biosimilars, 2021-2025

Biosimilars – Providing Affordable, Accessible Care for Patients

Cost Savings with Biosimilars in Rheumatology: A Systematic Literature Search of Budget Impact Analysis

BIosimilar Report 2023 (Cardinal)